Literature DB >> 2420219

An immunohistochemical study of thymic epithelial tumors. I. Epithelial component.

T Kodama, S Watanabe, Y Sato, Y Shimosato, N Miyazawa.   

Abstract

Twenty-four cases of thymic epithelial tumors, including 18 cases of thymoma, five cases of squamous cell carcinoma, and one case of undifferentiated carcinoma, were studied immunohistochemically using monoclonal antibody Leu-7 (HNK-1) and antikeratin antibody. Seven cases of non-neoplastic thymic tissues were also studied. Leu-7 antibody stained epithelial cells in the outer cortex of the normal thymus, and antikeratin antibody stained thymic epithelial cells in both cortex and medulla of the normal thymus. Seventeen thymomas and one undifferentiated carcinoma were focally or diffusely stained with Leu-7, some showing cortical and medullary differentiation as seen in the normal thymus. On the other hand, none of the five squamous cell carcinomas were stained with Leu-7. All thymomas stained for keratin in varying degrees, and all squamous cell carcinomas were diffusely and strongly stained with antikeratin antibody. It is concluded that normal thymic epithelial cells showed zonal differentiation, and neoplastic cells were considered to retain these characteristics to some extent; i.e., thymomas had the same phenotype of epithelial cells of the cortex, especially the outer cortex of the thymus in some instances (Leu-7-positive, keratin-positive) and of both cortex and medulla (mixture of Leu-7-positive and -negative cells) with organoid arrangement in other instances, and thymic squamous cell carcinoma had the same phenotype as epithelial cells in the thymic medulla (Leu-7-negative, keratin-positive).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420219     DOI: 10.1097/00000478-198601000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  12 in total

1.  A new monoclonal antibody to human subcapsular thymic epithelial cells.

Authors:  T Takeuchi; I Kubonishi; Y Ohtsuki; I Miyoshi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Immunohistochemical studies on a human thymic epithelial cell subset defined by the anti-cytokeratin 18 monoclonal antibody.

Authors:  W Savino; M Dardenne
Journal:  Cell Tissue Res       Date:  1988-10       Impact factor: 5.249

3.  Immunohistochemical study of 22 cases of thymoma.

Authors:  D Lee; D H Wright
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

4.  Immuno-architecture of human fetal lymphoid tissues.

Authors:  W Timens; A Boes; T Rozeboom-Uiterwijk; S Poppema
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

Review 5.  Thymic carcinoma. Report of five cases and review of the literature.

Authors:  C A Hartmann; C Roth; C Minck; G Niedobitek
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

6.  Microcytic variant of thymoma: histological and immunohistochemical findings in two cases.

Authors:  T Fukuda; Y Ohnishi; I Emura; S Tachikawa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 7.  The spectrum of ectopic thymomas.

Authors:  Annikka Weissferdt; Cesar A Moran
Journal:  Virchows Arch       Date:  2016-06-02       Impact factor: 4.064

8.  CD5 expression in thymic carcinoma.

Authors:  T Hishima; M Fukayama; M Fujisawa; Y Hayashi; K Arai; N Funata; M Koike
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

9.  Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases.

Authors:  H Asamura; T Nakajima; K Mukai; M Noguchi; Y Shimosato
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

10.  Expression patterns for Bcl-2, EMA, β-catenin, E-cadherin, PAX8, and MIB1 in thymomas.

Authors:  David Suster; James A Miller; German Pihan; A Craig Mackinnon; Saul Suster
Journal:  Mod Pathol       Date:  2021-06-16       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.